Mohamed Mubasher to Myopia
This is a "connection" page, showing publications Mohamed Mubasher has written about Myopia.
Connection Strength
0.566
-
Manny RE, Hussein M, Scheiman M, Kurtz D, Niemann K, Zinzer K. Tropicamide (1%): an effective cycloplegic agent for myopic children. Invest Ophthalmol Vis Sci. 2001 Jul; 42(8):1728-35.
Score: 0.202
-
Hyman L, Gwiazda J, Hussein M, Norton TT, Wang Y, Marsh-Tootle W, Everett D. Relationship of age, sex, and ethnicity with myopia progression and axial elongation in the correction of myopia evaluation trial. Arch Ophthalmol. 2005 Jul; 123(7):977-87.
Score: 0.067
-
Gwiazda JE, Hyman L, Norton TT, Hussein ME, Marsh-Tootle W, Manny R, Wang Y, Everett D. Accommodation and related risk factors associated with myopia progression and their interaction with treatment in COMET children. Invest Ophthalmol Vis Sci. 2004 Jul; 45(7):2143-51.
Score: 0.062
-
Manny RE, Hussein M, Gwiazda J, Marsh-Tootle W. Repeatability of ETDRS visual acuity in children. Invest Ophthalmol Vis Sci. 2003 Aug; 44(8):3294-300.
Score: 0.058
-
Gwiazda J, Hyman L, Hussein M, Everett D, Norton TT, Kurtz D, Leske MC, Manny R, Marsh-Tootle W, Scheiman M. A randomized clinical trial of progressive addition lenses versus single vision lenses on the progression of myopia in children. Invest Ophthalmol Vis Sci. 2003 Apr; 44(4):1492-500.
Score: 0.057
-
Gwiazda J, Marsh-Tootle WL, Hyman L, Hussein M, Norton TT. Baseline refractive and ocular component measures of children enrolled in the correction of myopia evaluation trial (COMET). Invest Ophthalmol Vis Sci. 2002 Feb; 43(2):314-21.
Score: 0.053
-
Hyman L, Gwiazda J, Marsh-Tootle WL, Norton TT, Hussein M. The Correction of Myopia Evaluation Trial (COMET): design and general baseline characteristics. Control Clin Trials. 2001 Oct; 22(5):573-92.
Score: 0.051
-
Kurtz D, Manny R, Hussein M. Variability of the ocular component measurements in children using A-scan ultrasonography. Optom Vis Sci. 2004 Jan; 81(1):35-43.
Score: 0.015